Back to Trades
Cunningham Ann Michelle
DirectorCIK 0001764572
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Cunningham Ann Michelle, Director, has filed 2 SEC reports (2025–2026), spread across 2 companies, totaling $63.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Apr 29 | ATHE ALTERITY THERAPEUTICS LTD | Cunningham Ann Michelle | Director | Other | $0 |
| Sep 11 | VTGN Vistagen Therapeutics, Inc. | Cunningham Ann Michelle | Director | Award | $63.5K |
2 filings